Description
This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 5
Primary Industries
- Drugs
- Pharmaceuticals
- Medical
- Wound Care
- Supply
- Therapeutic
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 6865
License Grant
Licensor hereby grants to Licensees a non-exclusive license under the Licensed Patents to make, have made, use, import, sell, promote, market, or offer for sale Licensed Products in the Licensed Fields throughout the Licensed Territories.
License Property
U.S. Patent No. 5,165,938 entitled Wound Healing Agents, issued 11/24/92
On 6/3/2005 it has reached settlement agreement LicenseeTechnologies for infringing or seeking to avoid infringement of the Company’s patents. The underlying patents expired in late November 2009.
Field of Use
Licensed Fields means any and all fields of use.
The Company has established its intellectual property rights arising from its process patents regarding the use of platelet releasates to heal damaged tissue.
IPSCIO Record ID: 6876
License Grant
The Company is party to certain royalty agreements relating to its intellectual property under which it pays certain fees.
License Property
Company has established its intellectual property rights arising from its process patents regarding the use of platelet releasates to heal damaged tissue. Over several years it has reached settlement and/or licensing Agreements with numerous companies infringing or seeking to avoid infringement of the Company’s patents. The underlying patents expired in late November 2009. These dates reflect the expiration of the License in the U.S., which coincides with the expiration of the Knighton Patent in the U.S.
The Licensor's current patent portfolio consists of more than 30 domestic and international patents that generally fall into the following families
• Process, formulation, and methods for utilizing platelet releasates to heal damaged tissue
• Biomarkers for wound healing treatment efficacy
• Peptides with anti-inflammatory properties
• Peptides with angiogenic properties
The above patent families encompass the Company’s AutoloGelTM System, CT-112 anti-inflammatory peptide, homologous growth factors, wound-healing biomarkers, and several other potential therapies.
Field of Use
The field of use relates to the medical industry.
IPSCIO Record ID: 28449
License Grant
Licensor hereby grants to Licensee a non-exclusive license under the Licensed Patents to make, have made, use, import, sell, promote, market, offer for sale or otherwise transfer Royalty-Bearing Products in the Licensed Fields throughout the world.
License Property
The Company established its intellectual property rights arising from its process patents regarding the use of platelet releasates to heal damaged tissue. Over several years it has reached settlement and/or licensing Agreements with numerous companies infringing or seeking to avoid infringement of the Company’s patents. These dates reflect the expiration of the License in the U.S., which coincides with the expiration of the Knighton Patent in the U.S. The Licensee agreement was effective 10/28/06 through 11/24/2009; controversy between the parties arising in connection with claims of infringement of U.S. Patent No. 5,165,938.
The Licensor's current patent portfolio consists of more than 30 domestic and international patents that generally fall into the following families
• Process, formulation, and methods for utilizing platelet releasates to heal damaged tissue
• Biomarkers for wound healing treatment efficacy
• Peptides with anti-inflammatory properties
• Peptides with angiogenic properties
The above patent families encompass the Company’s AutoloGelTM System, CT-112 anti-inflammatory peptide, homologous growth factors, wound-healing biomarkers, and several other potential therapies.
Field of Use
Licensed Fields means any and all fields of use, worldwide.
IPSCIO Record ID: 26656
License Grant
A U.S. pharma has granted the worldwide rights to a U.S business unit of an Italian company the Knighton patent for all applications relating to the use of autologous platelet releasate therapies for healing purposes (wound-healing and tissue repair therapies). U.S. Patent No. 5,165,938 entitled Wound Healing Agents.
License Property
5,165,938 A process for treating a wound of a live animal which comprises applying over the wound an effective amount of a treating composition containing the materials released by platelets during the platelet release reaction and facilitating healing of the wound.
Field of Use
Licensed Fields means any and all fields of use.
IPSCIO Record ID: 26542
License Grant
The Licensor granted the Licensee a non-exclusive License under the Licensed Patents to make, have made, use, import, sell, promote, market, offer for sale or otherwise transfer royalty-Bearing Products in the Licensed Fields throughout the world. This grant includes the right for the Licensee to grant subLicenses to this Agreement without payment of any additional royalty to the Licensor.
License Property
5,165,938 entitled 'Wound Healing Agents,' issued 11/24/92
Schedule of Disposable Products
Model Number Description UOM
7117-8200 Disposable Platelet Concentrator
(Market Evaluation Unit) One (1)
7117 8202 Disposable Platelet Concentrator One (1)
7117-8201 Graft Delivery System One (1)
7117-8203 Spray Applicator One (1)
7117-8204 Dual Lumen Applicator One (1)
Field of Use
“Licensed Fields†means all applications except use in treatment of diabetic foot ulcers, pressure ulcers, venous stasis and other wounds treated outside of surgery.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.
